Total investments received (USD): 63.04m
Round value (USD): 13.26m
Round investors:
Boehringer Ingelheim Venture Fund
Gründerfonds Ruhr
Company: Abalos Therapeutics








Netherlands
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain